U.S. Insurance Stock News

In March 2026, TriCo Bancshares filed a shelf registration to offer up to US$56.89 million, or 1,200,000 shares, of common stock tied to an employee stock ownership plan (ESOP) offering. This ESOP-related shelf registration highlights the bank’s use of equity-based employee incentives, which can affect both capital flexibility and ownership structure. With this new ESOP-linked shelf registration in place, we’ll examine how potential equity issuance could shape TriCo Bancshares’ investment...

McEwen Inc. has released a new Mineral Resource Estimate for its Tartan Mine Project in Manitoba, outlining 308,900 indicated and 302,700 inferred gold ounces (at a US$3,000/oz gold price) and progressing plans to restart the underground mine using existing 500 tpd permits. The company is pairing this resource update with a US$6,000,000 exploration budget, metallurgical test work including cyanide-free options, and assessment of a possible expansion to 1,000 tpd that could materially lift...

In its latest quarter, W.W. Grainger reported revenue ahead of expectations but slightly missed on adjusted EPS, experienced operating margin pressure from higher costs, and still generated strong operating cash flow while returning capital through dividends and buybacks. At the same time, Grainger outlined a multi-year growth plan focused on expanding sales and margins across its High-Touch Solutions and Endless Assortment segments, while being recognized again as a Fortune 100 Best...

Recent performance context for Chemed Chemed (CHE) has drawn fresh attention after a challenging year for the stock, with negative total returns over the past year and past 3 months prompting investors to reassess the business and its current valuation. See our latest analysis for Chemed. With the share price at $377.57, Chemed’s recent 10.4% 1 month share price decline and 11.75% 3 month share price decline sit alongside a 38.27% 1 year total shareholder return decline. This suggests...

Fastly (FSLY) has been back on traders’ screens after a relief rally in technology stocks and a 6.4% intraday move, along with the appointment of experienced marketing leader Joan Jenkins as Chief Marketing Officer. See our latest analysis for Fastly. Fastly’s recent 6.4% intraday move sits on top of a sharp upswing, with a 30 day share price return of 52.86% and a 1 year total shareholder return of 389.56%. This indicates that momentum has been building as investors reassess growth prospects...

Raytheon, an RTX business, has secured nearly $1b in new radar development contracts linked to the AN/TPY-2 missile defense radar. The company has received a $2b modification to its Advanced Extremely High Frequency (AEHF) satellite terminal contract with the U.S. government. RTX's BBN Technologies group has launched the Maude-HCS open-source cyber defense toolkit, funded by DARPA. For investors watching NYSE:RTX, these contract wins and product releases come at a time when the share price...

Energy Transfer stock overview after recent performance shifts Energy Transfer (ET) has seen mixed recent returns, with the unit price at $19.02 after a 1 day decline of 1.45% and a modest dip over the past month. At the same time, the units show gains of 15% over the past 3 months and 14.65% year to date, while the 1 year total return stands at 8.46% compared with very large 3 year and 5 year total return multiples. See our latest analysis for Energy Transfer. For context, the recent 1 day...

Norwegian Cruise Line Holdings recently overhauled its Board of Directors, appointing five new members with backgrounds at British Airways, Disney, Bain Capital, CDK Global, and Hepco Capital, while elevating CEO John Chidsey to Chairman and naming Alex Cruz as Lead Independent Director. This Board refresh brings in deep experience in travel operations, entertainment-focused finance, and private equity, potentially sharpening oversight of Norwegian’s cost discipline, fleet investments, and...

Travere Therapeutics is drawing fresh attention after traders reacted to the upcoming April 13, 2026 FDA PDUFA decision on a supplemental filing for its rare kidney disease drug FILSPARI in focal segmental glomerulosclerosis, alongside a recent analyst upgrade to a Buy rating. This combination of a potential label expansion in an area with limited treatment options and an improved analyst stance is sharpening focus on how central FILSPARI has become to Travere’s rare disease strategy. We’ll...

Recent returns and business snapshot SmartStop Self Storage REIT (SMA) has traded around US$30.43 recently, with a 1 day total return near 0.5%. The stock shows negative returns over the past week, month, past 3 months and year. The company reports annual revenue of about US$267.83 million and a net loss of roughly US$9.39 million, with a value score of 4 and an indicated intrinsic discount figure of about 44%. SmartStop’s operations center on self storage. The company reports segment revenue...

DraftKings (DKNG) is back in focus after a federal judge dismissed a Washington D.C. lawsuit that challenged the legality of online sports betting, easing one regulatory overhang for operators in that market. See our latest analysis for DraftKings. Even with the legal win in Washington D.C., DraftKings’ share price has a 1-day share price return of 2.5% and 7-day share price return of 3.45%. This is set against a 30-day share price return of 6.97% and year-to-date share price return of...

Why the VF 9 launch matters for VinFast Auto (NasdaqGS:VFS) investors VinFast Auto (NasdaqGS:VFS) is in focus after introducing the VF 9, a fully electric three row SUV aimed at families that want more space, comfort, and clearer long term ownership support. See our latest analysis for VinFast Auto. The VF 9 launch arrives alongside a sharp pickup in momentum, with a 7-day share price return of 32.69% and a 1-year total shareholder return of 28.93%, even as the 3-year total shareholder return...

Why Copa Holdings Is On Investors’ Radar Today Copa Holdings (NYSE:CPA) has been drawing attention after recent share price moves, with the stock up 3.8% over the past day but showing a 10.7% decline over the past month. See our latest analysis for Copa Holdings. The recent 1-day share price return of 3.79% and 7-day share price return of 2.28% come after a softer patch, with a 30-day share price return of negative 10.67%, while the 1-year total shareholder return of 37.80% points to...

Recent analyst upgrades and renewed optimism around Ichor Holdings (ICHR) margins during a semiconductor upcycle have coincided with a 9.86% intraday rally, drawing attention to fresh technical signals and heavy options activity. See our latest analysis for Ichor Holdings. The latest 2.57% 1 day share price return takes Ichor Holdings to US$47.81. A 159.41% 90 day share price return and 134.25% year to date share price return contrast with a 111.46% 1 year total shareholder return, pointing...

Arcos Dorados Holdings (NYSE:ARCO) has approved a cash dividend for 2026. The dividend is scheduled to be paid to shareholders in quarterly installments throughout 2026. The board decision sets out a defined timetable for cash returns to shareholders next year. Arcos Dorados, the largest independent McDonald’s franchisee in Latin America and the Caribbean, continues to operate in a consumer environment shaped by inflation pressures, shifting spending patterns and ongoing investment in...

DoubleVerify Holdings (DV) is back in focus after announcing that Spectrum Reach will be the first participant in its Certified Transparent Streaming program, bringing program level transparency to streaming TV ad placements. See our latest analysis for DoubleVerify Holdings. The Spectrum Reach partnership arrives at a time when DoubleVerify’s 1 day share price return of 2.95% contrasts with a weaker 30 day share price return of 6.68% and a 1 year total shareholder return decline of 26.96%,...

Corcept Therapeutics (NasdaqCM:CORT) presented new late breaking MOMENTUM trial data at the American College of Cardiology 2026 Annual Scientific Session. The study reported a high prevalence of previously undiagnosed endogenous hypercortisolism in patients with resistant hypertension. The findings suggest a larger pool of patients who might be candidates for therapies that target hypercortisolism. For you as a shareholder or potential investor, this update adds an extra layer to the usual...

Helios Technologies recently reported stronger-than-expected fourth-quarter 2025 non-GAAP earnings of US$0.81 per share with growth in both Electronics and Hydraulics segments, while also declaring a quarterly dividend of US$0.12 per share payable on April 27, 2026, to shareholders of record on April 13, 2026. Through its Balboa Water Group subsidiary, Helios is deepening its more-than-decade-long partnership with Jacuzzi Group by supplying advanced control, display, and multi-zone lighting...

American Express (AXP) is leaning further into sports and entertainment with a new multi year global partnership that will name the company the NFL’s Official Payments Partner starting in the 2026 season. See our latest analysis for American Express. The NFL partnership lands at a time when American Express shares trade at US$301.45, with recent share price returns weaker over the past quarter and year to date, while multi year total shareholder returns remain firmly positive. This suggests...

U.S. Gold Corp. (NasdaqCM:USAU) released its Feasibility Study results for the fully permitted CK Gold Project in Wyoming. The study outlines project economics and highlights options such as mine expansion, longer mine life and additional revenue sources. The CK Gold Project is described as shovel ready, with all key permits in place. U.S. Gold, trading at $15.8, sits at a notable point in its development, with the CK Gold Project having cleared a major technical and regulatory hurdle. The...

If you are wondering whether Syndax Pharmaceuticals' current share price reflects its true worth, this article walks through the key valuation checks that can help you frame that question clearly. The stock recently closed at US$23.88, after a 7.9% gain over the past month, a 12.1% return year to date, and 84.1% over the last year. These moves may have changed how the market views both its potential and its risks. Recent coverage has focused on Syndax Pharmaceuticals in the context of its...

In recent weeks, Mosaic reported mixed earnings as higher potash and phosphate prices were offset by lower volumes and rising production costs, while phosphate markets were described as tight due to limited new supply. At the same time, UBS and Bank of America downgraded Mosaic, highlighting potash oversupply risks, pressure on phosphate margins from higher sulfur and ammonia costs, and progress on the company’s Brazilian rare-earths joint venture now moving into prefeasibility with...

Antitrust lawsuit raises fresh questions for Vail Resorts stock A new federal antitrust class action against Vail Resorts (MTN) and Alterra Mountain Company is challenging how the two major operators price and bundle their ski passes across North America. The complaint, filed in the U.S. District Court for the District of Colorado, alleges that season pass bundles and single day lift-ticket pricing practices have restricted competition and pushed costs higher for skiers and snowboarders. See...

Investors may be wondering whether Community Trust Bancorp at around US$61.58 still offers value, or if most of the upside is already reflected in the price. The stock has returned 2.4% over the last week, 0.1% over the past month, 9.2% year to date and 26.6% over the last year, with longer term returns of 86.2% over 3 years and 70.3% over 5 years. Recent coverage has focused on Community Trust Bancorp's position in the regional banking space and how investors are assessing its fundamentals...